| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/03/1995 | EP0650363A1 Antiviral combinations |
| 05/03/1995 | EP0650362A1 Antiviral combinations |
| 05/03/1995 | EP0650361A1 Compositions for the treatment of arthritis containing phosphonates and nsaids |
| 05/03/1995 | EP0650360A1 Phosphono derivatives as antiinflammatory and antiarthritic agents |
| 05/03/1995 | EP0650359A1 TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING THE ACTIVE SUBSTANCE 17-$g(b)-OESTRADIOL (ANHYDROUS) |
| 05/03/1995 | EP0650358A1 17-acyl-4-aza-steroid-3-one as 5-alpha-reductase inhibitors |
| 05/03/1995 | EP0650357A1 Rapamycin derivatives |
| 05/03/1995 | EP0650356A1 Rapamycin derivatives |
| 05/03/1995 | EP0650355A1 Medicaments for the treatment of visceral pain and migraine |
| 05/03/1995 | EP0650331A1 Food products containing benzimidazole |
| 05/03/1995 | EP0626953A4 Novel sidechain-bearing taxanes and intermediates thereof. |
| 05/03/1995 | EP0586488B1 Pharmaceutical enema preparation |
| 05/03/1995 | EP0557336B1 Use of 2h-1,2,4-benzothiadiazine-3(4h)-thion-1,1-dioxides as antiviral medicaments |
| 05/03/1995 | EP0541594B1 Cyclopentane derivatives, process for producing them and their pharmaceutical use |
| 05/03/1995 | EP0535231B1 Pyrimidine nucleoside derivative |
| 05/03/1995 | EP0470144B1 Beta-hydroxamate d-aspartic acid for treatment of viral infections and tumours |
| 05/03/1995 | EP0456724B1 Composition and method for treating benign prostatic hypertrophy |
| 05/03/1995 | EP0126152B1 A method of treatment of atherosclerosis & a balloon catheter for same |
| 05/03/1995 | CN1102186A Determination and usage of new component of traditional Chinese medicine Chinese onion |
| 05/03/1995 | CN1102185A Substituted thiacycloalkeno |3,2-b¨ pyridines, methods of preparation, compositions and method of use |
| 05/03/1995 | CN1102184A Novel pyridonecarboxylic acid derivatives and processes for preparing the same |
| 05/03/1995 | CN1102179A Zinc acelylsalicylate |
| 05/03/1995 | CN1102096A Anti-inflammatory antipyretic suppository for animals |
| 05/03/1995 | CN1102095A Long-acting androgen preparation-undecylic acid testis injection |
| 05/03/1995 | CN1102094A Granular preparation |
| 05/03/1995 | CN1102093A Isoniazid aerosol, spray and preparation method thereof |
| 05/03/1995 | CA2134866A1 Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals |
| 05/03/1995 | CA2134865A1 Substituted heterocyclic carboxamide esters, their preparation and their use as pharmaceuticals |
| 05/03/1995 | CA2134630A1 1-[2h-1-benzopyran-2-one-8-yl]-piperazine derivatives |
| 05/02/1995 | US5412145 P2'-modified hydroxamic acid collagenase inhibitors |
| 05/02/1995 | US5412141 Bisphosphonic acid derivatives as anti-arthritic agents |
| 05/02/1995 | US5412127 Process for extracting minor fatty compounds from a substance of biological origin |
| 05/02/1995 | US5412116 Oxidation of glycoside substituted taxanes to taxol or taxol precursors and new taxane compounds formed as intermediates |
| 05/02/1995 | US5412104 Hypotensive and antiviral agents |
| 05/02/1995 | US5412102 Angiotensin II receptor antagonist |
| 05/02/1995 | US5412101 Sulphorous derivatives of imidazole, and their use as medicaments and the pharmaceutical compositions containing them |
| 05/02/1995 | US5412095 Terazosin monohydrochloride and processes and intermediate for its production |
| 05/02/1995 | US5412094 Bicyclic beta-lactam/paraben complexes |
| 05/02/1995 | US5412093 3-heterocyclic thiomethyl cephalosporins |
| 05/02/1995 | US5412089 Antitumor, antiviral |
| 05/02/1995 | US5412072 Water soluble high molecular weight polymerized drug preparation |
| 05/02/1995 | US5411993 Anti-inflammatory, stable aqueous preparation comprising azulene sodium sulfonate and polyhydric alcohol |
| 05/02/1995 | US5411991 Applying to human skin, beards, reaction with cysteine |
| 05/02/1995 | US5411989 Nitric acid esters of cyclohexanol derivatives |
| 05/02/1995 | US5411988 Compositions and methods for inhibiting inflammation and adhesion formation |
| 05/02/1995 | US5411986 Chemoprotective isothiocyanates |
| 05/02/1995 | US5411985 Gamma-pyrone-3-acetic acid as an inhibitor or interleukin-1 β inventory enzyme |
| 05/02/1995 | US5411982 Cycloalkylene azoles, and their use as aromatase inhibitors |
| 05/02/1995 | US5411978 Benzisothiazolinone-1-dioxide derivatives as elastase inhibitors |
| 05/02/1995 | US5411976 New thiazolidine derivatives, process for preparing same and anti-amnestic composition containing same |
| 05/02/1995 | US5411975 Thiazolidinyl terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
| 05/02/1995 | US5411973 Therapeutic alcohols |
| 05/02/1995 | US5411971 N-alkylenepiperidino compounds, their enantiomers and pharmaceutical compositions |
| 05/02/1995 | US5411968 Treatment of anxiety |
| 05/02/1995 | US5411967 Carbamates of rapamycin |
| 05/02/1995 | US5411965 Use of delta opioid receptor antagonists to treat cocaine abuse |
| 05/02/1995 | US5411962 Benzomorpholinyl-terminated non-peptidyl α-succinamidoacyl aminodiols as anti-hypertensive agents |
| 05/02/1995 | US5411961 Benzo-fused morpholinyl terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
| 05/02/1995 | US5411960 Substituted pyrroloanthracenes and -diones |
| 05/02/1995 | US5411959 1,4-Thiomorpholino-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
| 05/02/1995 | US5411958 Benzothiomorpholinyl-terminated non-peptidyl α-succinamidoacyl aminodiols as anti-hypertensive agents |
| 05/02/1995 | US5411957 3-azabicyclo[3.2.1]-nonanyl-terminated non-piptidyl alpha-succinamidoacyl aminodiols as anti-hypertensive agents |
| 05/02/1995 | US5411956 Lipolytic enzyme inhibitors |
| 05/02/1995 | US5411955 Thiadiazinecarboxamide derivatives, processes for their preparation and pharmaceuticals |
| 05/02/1995 | US5411954 Benzo-fused oxazopinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
| 05/02/1995 | US5411953 Oxazopinyl terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
| 05/02/1995 | US5411950 Benzo-fused oxazocinyl terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
| 05/02/1995 | US5411949 23-oxa-derivatives in the vitamin D series, process for their production, pharmaceutical preparations containing these derivatives as well as their use pharmaceutical agents |
| 05/02/1995 | US5411948 Use of host cell phospholipids for inhibiting microbial colonization |
| 05/02/1995 | US5411947 converting drugs having suitable functional groups to 1-O-alkyl-, 1-O-acyl-, 1-S-acyl, and 1-S-alkyl-sn-glycero-3-phosphate derivatives; drugs such as AZT, cladribine, AICA-Riboside |
| 05/02/1995 | US5411745 Powder layer beads for sustained release analgesics |
| 05/02/1995 | US5411743 Prevention of synovial adhesions |
| 05/02/1995 | US5411742 Compositions for the treatment of acne containing a derivative of salicylic acid and derivatives of salicylic acid |
| 05/02/1995 | US5411741 Method and composition for skin depigmentation |
| 05/02/1995 | US5411740 Transdermal administration of oxybutynin |
| 05/02/1995 | US5411739 Transdermal delivery of nicotine |
| 05/02/1995 | US5411738 Maintaining lidocaine intradermally at a concentration sufficient to induce analgesia |
| 05/02/1995 | US5411737 Slow release syneresing polymeric drug delivery device |
| 05/02/1995 | US5411734 Cosmetics with ester compounds in mixtures |
| 05/02/1995 | US5411728 Sunscreen agents |
| 05/02/1995 | CA2134707A1 Methods and compositions for retarding the aging process |
| 05/02/1995 | CA2097337A1 Jesalt - herbal oil canada |
| 05/02/1995 | CA1335452C Substituted tetralins, chromans and related compounds in the treatment of asthma |
| 05/02/1995 | CA1335451C Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases |
| 05/02/1995 | CA1335450C Indole and indazole keto sulphones as leukotriene antagonists |
| 04/30/1995 | CA2134627A1 Epoxysuccinic acid derivatives |
| 04/30/1995 | CA2134610A1 Compositions containing piperine |
| 04/30/1995 | CA2134194A1 Medicine for the treatment of tumor |
| 04/29/1995 | CA2134536A1 Cyclized analogues of fatty acid, process for their preparation and pharmaceutical compositions containing them |
| 04/29/1995 | CA2134304A1 Methods for inhibiting uterine fibrosis |
| 04/29/1995 | CA2133620A1 Aminoquinoline derivatives |
| 04/27/1995 | WO1995011438A1 Modified-release dosage form dissolution control method using a solid reagent, and single-dose sachet containing said reagent |
| 04/27/1995 | WO1995011310A1 Antifungal antibiotic cepacidine a |
| 04/27/1995 | WO1995011254A1 16-substituted-4-aza-androstane 5-alpha-reductase isozyme 1 inhibitors |
| 04/27/1995 | WO1995011253A1 A method for enhancing neurone survival and agents useful for same |
| 04/27/1995 | WO1995011246A1 Process for preparing n-(2,6-dichloro-3-methylphenyl)-5-7-dihalo[1,2,4]triazolo[1,5a]pyrimidine-2-sulfonamide by cyclization and halo-dehydroxylation |
| 04/27/1995 | WO1995011244A1 Pyridazino quinoline compounds |
| 04/27/1995 | WO1995011243A1 Benzanilide derivatives as 5ht-1d receptor antagonists |
| 04/27/1995 | WO1995011242A1 Phenyl or heteroaryl and tetrahydronaphthyl substituted diene compounds having retinoid like biological activity |
| 04/27/1995 | WO1995011240A1 Amine derivatives as calcium channel antagonists |